- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Mephentermine is a sympathomimetic amine used in the treatment of cardiovascular diseases. It is a derivative of ephedrine and is used to treat hypertension, angina, and congestive heart failure. It is also used to treat arrhythmias, such as atrial fibrillation and ventricular tachycardia. Mephentermine is available in both oral and intravenous forms. It is usually prescribed in combination with other drugs, such as diuretics, beta-blockers, and calcium channel blockers.
Mephentermine is a widely used drug in the treatment of cardiovascular diseases. It is generally well tolerated and has few side effects. However, it can cause dry mouth, insomnia, and restlessness. It is important to follow the doctor's instructions when taking mephentermine.
Some companies in the mephentermine market include Pfizer, Merck, Novartis, and GlaxoSmithKline. These companies produce and market mephentermine in various forms, such as tablets, capsules, and injections. Show Less Read more